From AI Labs to Empty Shell: VERSES AI Loses Its Scientific Heart and Last Hope

The day VERSES AI shut down its artificial intelligence operations, it wasn’t just a corporate decision — it was the end of a scientific experiment. On June 18, 2026, the board voted to abandon all AI-related activities, including the “Genius” platform that had been built on Nobel-caliber neuroscience. The man who gave that platform its theoretical foundation, Chief Science Officer Karl Friston, had already walked out the door.

Friston, a world-renowned neuroscientist, provided the intellectual backbone of VERSES AI through his concept of “active inference.” His departure stripped the company of any remaining claim to being a serious player in the AI space. Alongside him, President and COO James Hendrickson and CTO Hari Thiruvengada resigned, citing disputes with the board over unpaid employee salaries. The exodus follows the February resignations of founder and CEO Gabriel René, co-founder and brand ambassador Dan Mapes, and former CFO Kevin Wilson. None of those three positions have been filled.

Interim CEO David Scott, who took over in February, spent four months trying to keep the company alive. He held merger talks, courted investors, and explored asset sales — all without a single completed deal. “We have made exhaustive efforts over the past four months,” Scott said. “We were unable to close a single transaction.” With no fresh capital raised, the board pulled the plug on research, development, and every expense tied to AI.

The numbers tell a story of financial exhaustion. At the end of the day, VERSES AI had roughly 68,000 Canadian dollars in cash against nearly two million dollars in liabilities. Its net loss for fiscal 2026 came to approximately 43 million dollars, while revenue over the trailing twelve months totaled just 155,000 dollars. The stock, which hit a 52-week high of 24.48 Canadian dollars, last traded at around 0.60 dollars — a decline of more than 96 percent. In the five trading sessions before the halt, the share price plunged 43 percent, leaving a market capitalization of about 3.74 million dollars.

Should investors sell immediately? Or is it worth buying VERSES AI?

The company had pinned its hopes on a ten-year licensing agreement with Prodigii AI, announced in April, which guaranteed minimum payments of 5.35 million US dollars. That deal has now been terminated, along with a consulting relationship with a major global investment house. What remains is intellectual property, but without an operating business, its value is impossible to determine.

Cboe Canada suspended trading in VERSES AI shares and warrants on June 19, 2026, and initiated a 90-day review period. The company must demonstrate it can meet continued listing requirements by mid-September. VERSES AI itself warns there is no guarantee that the ongoing strategic review will yield a transaction that secures its survival.

With no active business, no executive team, and 68,000 dollars in the bank, the clock is ticking faster than the cash. Bankruptcy proceedings look increasingly like the next stop.